Maven Clinic Review
Maven Clinic is a women's and family health telehealth platform founded in 2014 — among the earliest in the category — that has grown into one of the largest employer-sponsored women's health benefits in the United States. Its clinical programs cover fertility support, maternity care, postpartum recovery, menopause management, and weight management including GLP-1 prescriptions. Unlike most telehealth platforms reviewed on Telehealth Ally, Maven is primarily an employer benefits product: the maj
Quick Facts
| Starting Price | Contact provider |
| Medications | 1 peptides |
| Consultation | Video Telehealth |
| Shipping | 3-5 business days |
| Lab Testing | Not included |
| Prescriber | Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility. |
Maven Clinic offers 1 peptides for GLP-1 therapy. Maven Clinic is a women's and family health telehealth platform founded in 2014 — among the earliest in the category — that has grown into one of the largest employer-sponsored women's health benefits in the United States. Its clinical programs cover fertility support, maternity care, postpartum recovery, menopause management, and weight management including GLP-1 prescriptions. Unlike most telehealth platforms reviewed on Telehealth Ally, Maven is primarily an employer benefits product: the maj
Pros & Cons
What We Like
- Employer-sponsored model means many patients access comprehensive women's health care including GLP-1 prescribing at no out-of-pocket cost
- Longitudinal women's health approach
- Breadth of services enables integrated care across fertility, maternity, menopause, and weight management with the same platform
- Clinical quality accountability to employer purchasers creates structural pressure toward outcomes rather than volume
- Established platform with a decade of operational history in women's telehealth
- Large provider network improves appointment availability and specialist matching
Watch Out For
- Primarily an employer benefit; patients without employer access may find direct-to-consumer access limited or expensive
- GLP-1 services may not be uniformly available across all employer plans
- Breadth means no single clinical program is as specialized as a condition-specific platform (e.g., PCOS-specific or thyroid-specific care)
- Patients who change employers lose access unless enrolled in direct-to-consumer plan; care continuity is employer-dependent
- Less transparent public pricing than direct-to-consumer GLP-1 platforms
- Weight management may be lower priority relative to fertility and maternity in Maven's product development
Pricing Breakdown
Pricing not yet verified for Maven Clinic. Visit their site for current pricing →
Medications Offered
1 peptides available through Maven Clinic.
Considering Maven Clinic?
Request a free, no-obligation consultation. We'll share your details with Maven Clinicand they'll reach out within 1–2 business days.
Maven Clinic — Full Profile
Maven Clinic — Provider Profile
Overview
Maven Clinic is a women's and family health telehealth platform founded in 2014 — among the earliest in the category — that has grown into one of the largest employer-sponsored women's health benefits in the United States. Its clinical programs cover fertility support, maternity care, postpartum recovery, menopause management, and weight management including GLP-1 prescriptions. Unlike most telehealth platforms reviewed on Telehealth Ally, Maven is primarily an employer benefits product: the majority of patients access it through their workplace at $0 or low cost, with the employer covering the subscription fee.
This employer-benefit structure shapes the clinical experience in meaningful ways. Maven's incentive is to demonstrate outcomes to corporate purchasers — reduced comorbidities, fewer high-cost claims, better maternal outcomes — which creates pressure toward genuine clinical quality rather than simply volume-driven prescription throughput. The longitudinal relationship model, in which a patient might use Maven during fertility treatment, through pregnancy, and again during menopause or weight management, aligns the platform's incentives with long-term health outcomes rather than transactional visits.
GLP-1 prescriptions at Maven are offered within the context of women's health rather than as standalone weight-loss products. This matters clinically: weight management in women has distinct considerations across different life stages — PCOS during reproductive years, gestational weight concerns during pregnancy, metabolic shifts during menopause — and a platform with longitudinal women's health expertise is better positioned to navigate these than a general obesity medicine platform. Verify the current scope of Maven's GLP-1 program and direct-to-consumer pricing at mavenclinic.com.
Medications Offered
- GLP-1 receptor agonists for weight management (verify current formulary at mavenclinic.com)
- Fertility-related medications (within fertility support programs)
- Menopause hormone therapy
- Other women's health medications as clinically indicated within program scope
Pricing
| Access Model | Monthly Cost | What's Included |
|---|---|---|
| Employer-sponsored (most common) | $0 to employee | Full Maven benefit; employer covers subscription |
| Direct-to-consumer | Verify at mavenclinic.com | Individual access; pricing not publicly standardized |
| GLP-1 medications | Separate; varies by pharmacy/plan | Prescriptions sent to patient's pharmacy |
Most patients access Maven through employer benefits, often at no direct cost. For patients without employer access, direct-to-consumer availability and pricing should be verified at mavenclinic.com. GLP-1 medication costs are separate from the Maven subscription and depend on the patient's insurance coverage and pharmacy.
States Served
Maven operates across all U.S. states. State-specific service availability may vary for certain clinical programs. Employer contracts may specify covered services differently by plan. Verify service scope with your employer benefits portal or at mavenclinic.com.
Insurance
- Most patients are covered through employer-sponsored benefits; no additional insurance claim needed for Maven subscription
- GLP-1 medications may be covered under the patient's pharmacy benefits depending on their employer plan and clinical indication
- For direct-to-consumer patients, some services may be billable to insurance; verify with Maven and your insurer
- Employer plans may include GLP-1 coverage as part of a broader metabolic health benefit
Consultation Process
Model: Video consultations with women's health specialists; ongoing care team messaging; integrated with employer benefits
- Access Maven through employer benefits portal or enroll directly at mavenclinic.com
- Complete intake covering health history, current life stage (fertility, maternity, menopause, weight management), and goals
- Matched with providers appropriate to the program (OB/GYN, midwife, nutritionist, mental health counselor, or weight management specialist as indicated)
- Initial video consultation; labs may be ordered or reviewed depending on clinical program
- Treatment plan developed; GLP-1 evaluation within the context of women's metabolic health
- Ongoing follow-ups; care continuity across life stages if patient continues using Maven benefit
Pros
- Employer-sponsored model means many patients access comprehensive women's health care including GLP-1 prescribing at no out-of-pocket cost
- Longitudinal women's health approach — GLP-1 prescribing is embedded in ongoing women's health relationships, not isolated weight-loss visits
- Breadth of services enables integrated care across fertility, maternity, menopause, and weight management with the same platform
- Clinical quality accountability to employer purchasers creates structural pressure toward outcomes rather than volume
- Established platform with a decade of operational history in women's telehealth
- Large provider network improves appointment availability and specialist matching
Cons
- Primarily an employer benefit; patients without employer access may find direct-to-consumer access limited or expensive
- GLP-1 services may not be uniformly available across all employer plans — depends on what the employer has contracted
- Breadth means no single clinical program is as specialized as a condition-specific platform (e.g., PCOS-specific or thyroid-specific care)
- Patients who change employers lose access unless enrolled in direct-to-consumer plan; care continuity is employer-dependent
- Less transparent public pricing than direct-to-consumer GLP-1 platforms — hard to evaluate cost without checking through employer portal
- Weight management may be lower priority relative to fertility and maternity in Maven's product development
Best For
Women who have Maven as an employer benefit and want to consolidate women's health care — including weight management and GLP-1 therapy — on a single platform with longitudinal provider relationships. Particularly well-suited for women who are actively managing multiple health priorities (fertility planning, perimenopausal metabolic changes, postpartum weight management) simultaneously and want those addressed within a coherent clinical framework rather than across disconnected providers. Employees at large companies should check their benefits portal before seeking a separate GLP-1 telehealth subscription, as Maven access may already be included at no cost.
Editorial Verdict
Maven Clinic represents a structurally different model than the direct-to-consumer GLP-1 platforms that dominate this category. It is not optimized for the individual patient browsing for the lowest monthly cost on a weight-loss subscription; it is optimized for employers seeking to deliver measurable women's health outcomes as a benefits strategy. That structural difference has real implications for clinical quality — employer purchasers with data on outcomes create accountability that consumer subscription models do not.
For women who already have Maven through their employer, it is likely the most cost-effective and clinically coherent option available. The ability to manage GLP-1 therapy alongside fertility support, menopause care, or postpartum health within a single platform — with providers who understand the interplay — is something direct-to-consumer weight-loss platforms cannot replicate. The longitudinal relationship model also means that a provider prescribing a GLP-1 at Maven has access to the patient's prior women's health history, which is a meaningful clinical input that a one-off weight-loss telehealth visit lacks.
The limitation is access. Maven's employer-benefit model makes it largely inaccessible to the self-employed, part-time workers, or anyone whose employer does not offer the benefit. Direct-to-consumer enrollment exists but lacks the pricing transparency of most standalone telehealth platforms. For patients without employer access who are specifically seeking GLP-1 prescribing, a dedicated weight management telehealth platform with published pricing will likely be more straightforward to navigate.
Related Content
Patient Reviews
No patient reviews on Telehealth Ally yet. Be the first to review Maven Clinic
Used Maven Clinic? Help others decide.
Leave your email and we'll send you a short, 3-minute review form. Your honest experience helps the next patient make a better choice.
We'll only email you once about this review. No spam. Write a review now
How Maven Clinic Compares
See how Maven Clinic stacks up against other GLP-1 providers.
Provider Comparisons
Medication Comparisons
Ready to explore Maven Clinic?
Based on our independent review, Maven Clinic offers 1 peptides for GLP-1 therapy. Request a free consultation or visit their site to get started.
Telehealth Ally may receive compensation when you request a consultation. This does not affect our rankings or reviews.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
How We Review Providers
Our editorial team independently evaluates every telehealth provider based on pricing transparency, medication availability, clinical protocols, and patient experience. We verify pricing data weekly and update reviews when providers change their offerings. Revenue never influences our rankings or recommendations.
Read our editorial standards →